Gastroenterology Research and Practice / 2009 / Article / Tab 3

Research Article

Autonomic Testing in Functional Gastrointestinal Disorders: Implications of Reproducible Gastrointestinal Complaints during Tilt Table Testing

Table 3

Treatment choices in both groups.

Treatment groupOverallRGI NRGI

Volume expansion/ Fludrocortisone23/76 (30%)15/32 (47%)8/44 (18%)
Tricyclic antidepressant9/76 (12%)6/32 (19%)3/44 (7%)
Beta-blockers25/76 (32%)10/32 (31%)15/44 (34%)
Cyproheptadine3/76 (4%)2/32 (6%)1/44 (2%)
SSRI’s18/76 (23%)10/32 (31%)8/44 (18%)
Antiepileptic5/76 (6%)2/32 (6%)3/44 (7%)
Proamatine9/76 (12%)5/32 (16%)4/44 (9%)
Neurontin2/76 (2%)1/32 (3%)1/44 (2%)
Mestinon1/76 (1%)1/32 (3%)0/44 (0%)
No Treatment17/76 (22%)3/32 (9%)14/44 (31%)

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.